Skip to main content

Featured

Canadians Are Feeling Less Squeezed — But Fraud Is Rewriting How We Manage Credit

  New data from TransUnion's Q2 2026 Canada Consumer Pulse Study, released July 22, 2026 There's a small but real shift happening in Canadian households right now. After years of headlines about affordability and inflation, a new survey suggests things are slightly less bleak — but Canadians aren't relaxing. They're getting more careful, and increasingly, more worried about fraud than about their credit score. TransUnion's newest Consumer Pulse Study, out today, paints a picture of a country cautiously exhaling — while quietly tightening the locks on its financial front door. The Good News: A Little More Breathing Room For the first time in a while, the numbers aren't all doom. Roughly a quarter of Canadians surveyed said their household income rose over the past three months, and nearly one in four say their finances are running better than they expected this year — the best reading TransUnion has recorded in the past 12 months. Optimism is edging up too: 45% ...

article

Alzheimer’s vaccines get a boost from new drug approval

 

After decades of disappointment and controversy, the field of Alzheimer’s disease research has finally seen a breakthrough with the approval of the first drug that targets the underlying pathology of the condition. 

Aducanumab, a monoclonal antibody that clears amyloid plaques from the brain, was granted accelerated approval by the US Food and Drug Administration in June 2021, despite mixed results from clinical trials and objections from some experts. 

The drug’s approval has rekindled interest in other therapeutic approaches that aim to prevent or slow down the progression of Alzheimer’s, such as vaccines that stimulate the immune system to attack amyloid or tau, another protein that accumulates in the brains of people with the disease. 

Several vaccine candidates are currently in various stages of development and testing, and some researchers are optimistic that they could offer a more effective and convenient way to treat Alzheimer’s than infusions of antibodies.


Comments